Correction: CD36 enrichment in HER2-positive mesenchymal stem cells drives therapy refractoriness in breast cancer.
Saved in:
| Title: | Correction: CD36 enrichment in HER2-positive mesenchymal stem cells drives therapy refractoriness in breast cancer. |
|---|---|
| Authors: | Castagnoli L; Microenvironment and Biomarkers of Solid Tumors Unit, Department of Experimental Oncology, Amadeolab Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy., Franceschini A; Microenvironment and Biomarkers of Solid Tumors Unit, Department of Experimental Oncology, Amadeolab Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy., Cancila V; Tumor Immunology Unit, Department PROMISE, Universita' Di Palermo, Palermo, Italy., Dugo M; Breast Cancer Unit Clinical Translational and Immunotherapy Research, Department of Medical Oncology, IRCCS Ospedale San Rafaele, Milan, Italy., Bigliardi M; Microenvironment and Biomarkers of Solid Tumors Unit, Department of Experimental Oncology, Amadeolab Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy., Chiodoni C; Molecular Immunology Unit, Department of Experimental Oncology, Amadeolab Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy., Toneguzzo P; Microenvironment and Biomarkers of Solid Tumors Unit, Department of Experimental Oncology, Amadeolab Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy., Regondi V; Microenvironment and Biomarkers of Solid Tumors Unit, Department of Experimental Oncology, Amadeolab Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy., Corsetto PA; Department of Pharmacologicaland, Biomolecular Sciences 'Rodolfo Paoletti',, Università Di Milano, Milan, Italy., Pietrantonio F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy., Mazzucchelli S; Department of Biomedical and Clinical Sciences, Università Di Milano, Milan, Italy., Corsi F; Surgery Department, Istituti Clinici Scientifci Maugeri IRCCS, Pavia, Italy., Belfiore A; Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy., Vingiani A; Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy.; Department of Oncology and Hemato-Oncology, Universita' Di Milano, Milan, Italy., Pruneri G; Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy.; Department of Oncology and Hemato-Oncology, Universita' Di Milano, Milan, Italy., Ligorio F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy.; IFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy., Colombo MP; Molecular Immunology Unit, Department of Experimental Oncology, Amadeolab Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy., Tagliabue E; Microenvironment and Biomarkers of Solid Tumors Unit, Department of Experimental Oncology, Amadeolab Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy., Tripodo C; Tumor Immunology Unit, Department PROMISE, Universita' Di Palermo, Palermo, Italy.; IFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy., Vernieri C; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy.; IFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy., Triulzi T; Microenvironment and Biomarkers of Solid Tumors Unit, Department of Experimental Oncology, Amadeolab Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy., Pupa SM; Microenvironment and Biomarkers of Solid Tumors Unit, Department of Experimental Oncology, Amadeolab Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy. Serenella.Pupa@istitutotumori.mi.it. |
| Source: | Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2025 May 30; Vol. 44 (1), pp. 165. Date of Electronic Publication: 2025 May 30. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1756-9966 |
|---|---|
| DOI: | 10.1186/s13046-025-03426-3 |
